Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1975 1
1988 1
1990 1
1991 2
1992 1
1993 2
1994 2
1996 1
1997 2
1998 3
2000 4
2002 5
2003 4
2004 8
2005 6
2006 9
2007 8
2008 9
2009 11
2010 11
2011 18
2012 13
2013 20
2014 21
2015 38
2016 46
2017 25
2018 39
2019 58
2020 74
2021 88
2022 60
2023 49
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

591 results

Results by year

Filters applied: . Clear all
Page 1
A quality improvement programme to reduce hospital-acquired pressure injuries.
Gupta P, Shiju S, Chacko G, Thomas M, Abas A, Savarimuthu I, Omari E, Al-Balushi S, Jessymol P, Mathew S, Quinto M, McDonald I, Andrews W. Gupta P, et al. BMJ Open Qual. 2020 Jul;9(3):e000905. doi: 10.1136/bmjoq-2019-000905. BMJ Open Qual. 2020. PMID: 32727869 Free PMC article.
Primary trabeculectomy for advanced glaucoma: pragmatic multicentre randomised controlled trial (TAGS).
King AJ, Hudson J, Fernie G, Kernohan A, Azuara-Blanco A, Burr J, Homer T, Shabaninejad H, Sparrow JM, Garway-Heath D, Barton K, Norrie J, McDonald A, Vale L, MacLennan G; TAGS Study Group. King AJ, et al. BMJ. 2021 May 12;373:n1014. doi: 10.1136/bmj.n1014. BMJ. 2021. PMID: 33980505 Free PMC article. Clinical Trial.
PARTICIPANTS: 453 adults presenting with newly diagnosed advanced open angle glaucoma in at least one eye (Hodapp classification) between 3 June 2014 and 31 May 2017. ...
PARTICIPANTS: 453 adults presenting with newly diagnosed advanced open angle glaucoma in at least one eye (Hodapp classification) bet …
Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial.
Mateos MV, Cavo M, Blade J, Dimopoulos MA, Suzuki K, Jakubowiak A, Knop S, Doyen C, Lucio P, Nagy Z, Pour L, Cook M, Grosicki S, Crepaldi A, Liberati AM, Campbell P, Shelekhova T, Yoon SS, Iosava G, Fujisaki T, Garg M, Krevvata M, Chen Y, Wang J, Kudva A, Ukropec J, Wroblewski S, Qi M, Kobos R, San-Miguel J. Mateos MV, et al. Lancet. 2020 Jan 11;395(10218):132-141. doi: 10.1016/S0140-6736(19)32956-3. Epub 2019 Dec 10. Lancet. 2020. PMID: 31836199 Clinical Trial.
Here we report updated efficacy and safety results from a prespecified, interim, overall survival analysis of ALCYONE with more than 36 months of follow-up. METHODS: ALCYONE was a multicentre, randomised, open-label, active-controlled, phase 3 trial that enrolled patients …
Here we report updated efficacy and safety results from a prespecified, interim, overall survival analysis of ALCYONE with more than 36 mont …
First-line liposomal irinotecan with oxaliplatin, 5-fluorouracil and leucovorin (NALIRIFOX) in pancreatic ductal adenocarcinoma: A phase I/II study.
Wainberg ZA, Bekaii-Saab T, Boland PM, Dayyani F, Macarulla T, Mody K, Belanger B, Maxwell F, Moore Y, Thiagalingam A, Wang T, Zhang B, Dean A. Wainberg ZA, et al. Eur J Cancer. 2021 Jul;151:14-24. doi: 10.1016/j.ejca.2021.03.028. Epub 2021 May 4. Eur J Cancer. 2021. PMID: 33957442 Free article. Clinical Trial.
BACKGROUND: This open-label, phase I/II study evaluated safety and efficacy for first-line liposomal irinotecan + oxaliplatin + 5-fluorouracil + leucovorin (NALIRIFOX). ...
BACKGROUND: This open-label, phase I/II study evaluated safety and efficacy for first-line liposomal irinotecan + oxaliplatin + 5-flu …
Conservative management versus tonsillectomy in adults with recurrent acute tonsillitis in the UK (NATTINA): a multicentre, open-label, randomised controlled trial.
Wilson JA, O'Hara J, Fouweather T, Homer T, Stocken DD, Vale L, Haighton C, Rousseau N, Wilson R, McSweeney L, Wilkes S, Morrison J, MacKenzie K, Ah-See K, Carrie S, Hopkins C, Howe N, Hussain M, Mehanna H, Raine C, Sullivan F, von Wilamowitz-Moellendorff A, Teare MD. Wilson JA, et al. Lancet. 2023 Jun 17;401(10393):2051-2059. doi: 10.1016/S0140-6736(23)00519-6. Epub 2023 May 17. Lancet. 2023. PMID: 37209706 Free article. Clinical Trial.
We aimed to assess the clinical effectiveness and cost-effectiveness of conservative management versus tonsillectomy in patients with recurrent acute tonsillitis. METHODS: This pragmatic multicentre, open-label, randomised controlled trial was conducted in 27 hospitals in …
We aimed to assess the clinical effectiveness and cost-effectiveness of conservative management versus tonsillectomy in patients with recurr …
The unrestricted global effort to complete the COOL trial.
Kirkpatrick AW, Coccolini F, Tolonen M, Minor S, Catena F, Gois E Jr, Doig CJ, Hill MD, Ansaloni L, Chiarugi M, Tartaglia D, Ioannidis O, Sugrue M, Colak E, Hameed SM, Lampela H, Agnoletti V, McKee JL, Garraway N, Sartelli M, Ball CG, Parry NG, Voght K, Julien L, Kroeker J, Roberts DJ, Faris P, Tiruta C, Moore EE, Ammons LA, Anestiadou E, Bendinelli C, Bouliaris K, Carroll R, Ceresoli M, Favi F, Gurrado A, Rezende-Neto J, Isik A, Cremonini C, Strambi S, Koukoulis G, Testini M, Trpcic S, Pasculli A, Picariello E, Abu-Zidan F, Adeyeye A, Augustin G, Alconchel F, Altinel Y, Hernandez Amin LA, Aranda-Narváez JM, Baraket O, Biffl WL, Baiocchi GL, Bonavina L, Brisinda G, Cardinali L, Celotti A, Chaouch M, Chiarello M, Costa G, de'Angelis N, De Manzini N, Delibegovic S, Di Saverio S, De Simone B, Dubuisson V, Fransvea P, Garulli G, Giordano A, Gomes C, Hayati F, Huang J, Ibrahim AF, Huei TJ, Jailani RF, Khan M, Luna AP, Malbrain MLNG, Marwah S, McBeth P, Mihailescu A, Morello A, Mulita F, Murzi V, Mohammad AT, Parmar S, Pak A, Wong MP, Pantalone D, Podda M, Puccioni C, Rasa K, Ren J, Roscio F, Gonzalez-Sanchez A, Sganga G, Scheiterle M, Slavchev M, Smirnov D, Tosi L, Trivedi A, Vega JAG,… See abstract for full author list ➔ Kirkpatrick AW, et al. World J Emerg Surg. 2023 May 11;18(1):33. doi: 10.1186/s13017-023-00500-z. World J Emerg Surg. 2023. PMID: 37170123 Free PMC article. Clinical Trial.
Mortality typically results from disruption of the gastrointestinal tract, progressive and self-perpetuating bio-mediator generation, systemic inflammation, and multiple organ failure. A further therapeutic option may be open abdomen (OA) management with negative peritonea …
Mortality typically results from disruption of the gastrointestinal tract, progressive and self-perpetuating bio-mediator generation, system …
Open population maximum likelihood spatial capture-recapture.
Glennie R, Borchers DL, Murchie M, Harmsen BJ, Foster RJ. Glennie R, et al. Biometrics. 2019 Dec;75(4):1345-1355. doi: 10.1111/biom.13078. Epub 2019 Jul 25. Biometrics. 2019. PMID: 31045249
Open population capture-recapture models are widely used to estimate population demographics and abundance over time. Bayesian methods exist to incorporate open population modeling with spatial capture-recapture (SCR), allowing for estimation of the effective are …
Open population capture-recapture models are widely used to estimate population demographics and abundance over time. Bayesian method …
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
RECOVERY Collaborative Group. RECOVERY Collaborative Group. Lancet. 2022 Jan 8;399(10320):143-151. doi: 10.1016/S0140-6736(21)01825-0. Epub 2021 Nov 17. Lancet. 2022. PMID: 34800427 Free PMC article. Clinical Trial.
We aimed to evaluate the efficacy and safety of aspirin in patients admitted to hospital with COVID-19. METHODS: In this randomised, controlled, open-label, platform trial, several possible treatments were compared with usual care in patients hospitalised with COVID-19. .. …
We aimed to evaluate the efficacy and safety of aspirin in patients admitted to hospital with COVID-19. METHODS: In this randomised, control …
Cyclic Nucleotide Signaling in Phage Defense and Counter-Defense.
Athukoralage JS, White MF. Athukoralage JS, et al. Annu Rev Virol. 2022 Sep 29;9(1):451-468. doi: 10.1146/annurev-virology-100120-010228. Epub 2022 May 13. Annu Rev Virol. 2022. PMID: 35567297 Free article. Review.
Here we review the discovery and mechanism of the key pathways, signaling molecules and effectors, parallels and differences between the systems, open questions, and prospects for future research in this area....
Here we review the discovery and mechanism of the key pathways, signaling molecules and effectors, parallels and differences between the sys …
Paediatric glaucoma in Scotland.
Beck D, Galea M, Loo CY, Schmoll C, Burgess FR, Montgomery D, Tatham AJ. Beck D, et al. BMC Ophthalmol. 2020 Feb 27;20(1):76. doi: 10.1186/s12886-020-01347-7. BMC Ophthalmol. 2020. PMID: 32103740 Free PMC article.
591 results